Immediate Impact
8 from Science/Nature 54 standout
Citing Papers
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
Exploiting ferroptosis vulnerabilities in cancer
2024 Standout
Works of Andrew Avarbock being referenced
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Andrew Avarbock | 31 | 155 | 199 | 275 | 9 | 434 | |
| Vincent Escuyer | 16 | 179 | 165 | 239 | 12 | 456 | |
| Luke D. Handke | 5 | 84 | 201 | 281 | 14 | 472 | |
| Melinda R. Grosser | 6 | 43 | 153 | 260 | 14 | 478 | |
| Clément Vulin | 5 | 36 | 126 | 247 | 17 | 468 | |
| Rob van Dalen | 26 | 72 | 117 | 234 | 16 | 511 | |
| Josie F. Gibson | 5 | 119 | 190 | 189 | 8 | 457 | |
| John W. Annand | 3 | 163 | 224 | 227 | 7 | 497 | |
| Magdalena M. van der Kooi‐Pol | 12 | 103 | 168 | 167 | 10 | 424 | |
| Sebastian Kuhn | 6 | 29 | 142 | 239 | 9 | 390 | |
| Frances E. Rivera | 10 | 34 | 245 | 311 | 10 | 463 |
All Works
Loading papers...